Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
Clinical role
Detection/localization and immediate visualization/notification support; no quantification is provided
Images and patients
X-ray/Radiography · Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
Key limitation
Keep in mind: Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi Input: Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.
Who uses it?Intended users: Licensed qualified healthcare professionals trained to independently place or assess enteric tubes inserted nasally or orally, and radiologists
What does the software produce?Output: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
What is its most important limitation?Key limitation: Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.
Clinical takeaway. Clinical role: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
Evidence takeaway. Evidence from the reviewed source record: The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.
On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
Not for use in lieu of full patient evaluation or as the sole basis to make or confirm a diagnosis, and not a replacement for qualified-HCP review of the X-ray image. Side-port output is conditional on a side port being present.
The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The FDA clinical ground-truth study used 954 independent images from five sites across North America and the United Kingdom, spanning neonates to patients over 65 years, both chest and abdominal images, multiple tube types, varied image quality, and at least eight vendors. Five expert annotators performed two reads with arbitration. The packet reports enteric-tube detection sensitivity 0.992 (0.982, 0.997) and specificity 0.975 (0.947, 0.991); tube-tip sensitivity 0.957 (0.935, 0.973) and specificity 0.941 (0.901, 0.968); side-port sensitivity 0.931 (0.904, 0.952) and specificity 0.859 (0.801, 0.905); tube Dice 0.911 (0.912, 0.921), airway Dice 0.741 (0.730, 0.753), diaphragm Dice 0.821 (0.808, 0.834), and mean localization errors of 1.789 mm for the tube tip and 2.575 mm for the side port.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Critical Care Suite with Enteric Tube Positioning AI Algorithm regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult and Pediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K253502
Samplen=954
Sites5
IndependenceIndependence not established
K253502
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K253502. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Frontal chest and abdominal X-ray images from digital X-ray systems, including studies of patients with a nasally or orally inserted enteric tube; the evaluation included adult and pediatric images, including babygrams.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The software module can be deployed on PACS, on-premise, on-cloud, or digital projection radiographic systems; AMX Navigate mobile X-ray was the initial deployment platform. Results are sent as a secondary DICOM image and DICOM tag to a PACS, image-storage system, X-ray system, or other DICOM destination.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: On-screen overlays for the enteric tube, tube tip, side port if present, diaphragm, and airways; a secondary DICOM annotated image and DICOM tag identifying whether an enteric tube was detected. The comparison table reports no quantification output.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The software module can be deployed on PACS, on-premise, on-cloud, or digital projection radiographic systems; AMX Navigate mobile X-ray was the initial deployment platform. Results are sent as a secondary DICOM image and DICOM tag to a PACS, image-storage system, X-ray system, or other DICOM destination.
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.
GE HealthCare's product security page states that it provides a credentialed Product Security Portal offering security updates, vulnerability status and actions, and patch views for GE HealthCare products under its Cybersecurity Risk Management System, and links its Coordinated Vulnerability Disclosure Statement.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names GE HealthCare generally and does not scope these commitments to any specific product release; exact-release scope is not established. Portal access is credentialed; contents were not read.
ACR AI Central provides an exact-submission model card for Critical Care Suite with Enteric Tube Positioning AI Algorithm; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K253502 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.
Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Authorized purpose: Assists dentists in detecting caries, fillings/restorations, fixed prostheses, and implants on digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients aged 15 years and older; final diagnoses and treatment plans remain the dentist's responsibility.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.